KLF2 as a prognostic and potential therapeutic target associated with ferroptosis in serous ovarian cancer: An integrative bioinformatics and clinical validation study.

Wang Y, Yu J, Huang W, Yuan Y, Lan X, Jian Y, Li X, Wang S, Huang X, Xu G, Wei X

Open source

DOI
10.3892/ol.2026.15849
Published
2026 Nov
Container
Oncology letters
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ol.2026.15849,
  title = {KLF2 as a prognostic and potential therapeutic target associated with ferroptosis in serous ovarian cancer: An integrative bioinformatics and clinical validation study.},
  author = {Wang Y and Yu J and Huang W and Yuan Y and Lan X and Jian Y and Li X and Wang S and Huang X and Xu G and Wei X},
  year = {2026},
  journal = {Oncology letters},
  doi = {10.3892/ol.2026.15849},
  url = {https://doi.org/10.3892/ol.2026.15849}
}

RIS

TY  - JOUR
TI  - KLF2 as a prognostic and potential therapeutic target associated with ferroptosis in serous ovarian cancer: An integrative bioinformatics and clinical validation study.
AU  - Wang Y
AU  - Yu J
AU  - Huang W
AU  - Yuan Y
AU  - Lan X
AU  - Jian Y
AU  - Li X
AU  - Wang S
AU  - Huang X
AU  - Xu G
AU  - Wei X
PY  - 2026
JO  - Oncology letters
DO  - 10.3892/ol.2026.15849
UR  - https://doi.org/10.3892/ol.2026.15849
ER  - 

APA

Y, W., J, Y., W, H., Y, Y., X, L., Y, J., X, L., S, W., X, H., G, X., & X, W. (2026). KLF2 as a prognostic and potential therapeutic target associated with ferroptosis in serous ovarian cancer: An integrative bioinformatics and clinical validation study.. Oncology letters. https://doi.org/10.3892/ol.2026.15849

Source records